Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a
- 27 December 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 65 (12) , 1964-1966
Abstract
Immunologic response was assessed prospectively using influenza vaccine in 86 patients with multiple sclerosis (MS) who were taking interferon beta-1a and 77 patients who were not taking interferon. Blood samples were assayed for hemagglutination inhibition (HI) titers 0, 21, and 28 days after immunization. The two groups were similar in the proportion of patients achieving an HI titer of 40 or greater, the prespecified primary end point and on all secondary indicators of immune response.Keywords
This publication has 5 references indexed in Scilit:
- Serum Antibody Responses after Intradermal Vaccination against InfluenzaNew England Journal of Medicine, 2004
- Dose Sparing with Intradermal Injection of Influenza VaccineNew England Journal of Medicine, 2004
- Immunization and MS [RETIRED]Neurology, 2002
- Vaccinations and the Risk of Relapse in Multiple SclerosisNew England Journal of Medicine, 2001
- A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosisNeurology, 1997